Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma

Not Applicable

Completed

Conditions: Neuroblastoma

Interventions: Biological: Anti-GD2 3F8 Monoclonal Antibody
Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor)
Drug: oral isotretinoin

First Posted Date: 2014-04-01

Last Posted Date: 2020-02-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 69

Registration Number: NCT02100930

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Germ Cell Tumor and Testicular Tumor DNA Registry

Recruiting

Conditions: Germ Cell Tumor
Testicular Tumor

Interventions: Behavioral: Questionnaires
Other: sample of blood or saliva

First Posted Date: 2014-03-31

Last Posted Date: 2024-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1000

Registration Number: NCT02099734

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 5 locations

Regorafenib in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase 2

Completed

Conditions: Adenoid Cystic Carcinoma

Interventions: Drug: Regorafenib

First Posted Date: 2014-03-28

Last Posted Date: 2024-11-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 38

Registration Number: NCT02098538

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States

and more 1 locations

Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization

Not Applicable

Completed

Conditions: Tobacco Use Cessation

Interventions: Other: web-based video game (Quit IT)
Behavioral: Questionnaires
Other: Salvia sample

First Posted Date: 2014-03-28

Last Posted Date: 2020-12-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT02099097

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients

Phase 2

Completed

Conditions: Metastatic Castration-Resistant Prostate Cancer

Interventions: Drug: MLN0128

First Posted Date: 2014-03-19

Last Posted Date: 2019-11-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT02091531

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods

Not Applicable

Conditions: Healthy

Interventions: Behavioral: MR Screening Questionnaire
Device: Magnetic Resonance Imaging Acquisition and Analysis

First Posted Date: 2014-03-19

Last Posted Date: 2024-10-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 461

Registration Number: NCT02091518

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Kidney Cancer DNA Registry

Recruiting

Conditions: Renal Cancer

Interventions: Other: salvia for germline DNA
Behavioral: the Kidney Cancer Questionnaire
Behavioral: Family History Questionnaire (when applicable)
Other: Blood draw
Behavioral: Epidemiologic Questionnaire

First Posted Date: 2014-03-14

Last Posted Date: 2024-10-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 750

Registration Number: NCT02087852

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Consent and Follow-up), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack (Consent and Follow-up), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent and Follow up), Harrison, New York, United States

and more 4 locations

Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions

Phase 2

Active, not recruiting

Conditions: Breast Cancer

Interventions: Device: Breast MRI
Behavioral: Breast-Q© questionnaire
Radiation: Multi-Beam IMRT

First Posted Date: 2014-03-13

Last Posted Date: 2024-04-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 124

Registration Number: NCT02086578

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 4 locations

The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC

Completed

Conditions: Inpatients With Limited English Proficiency

Interventions: Behavioral: Patient Survey
Behavioral: Provider Survey

First Posted Date: 2014-02-27

Last Posted Date: 2020-01-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT02073903

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

Completed

Conditions: Prostate Cancer

Interventions: Other: blood draw

First Posted Date: 2014-02-25

Last Posted Date: 2023-10-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 200

Registration Number: NCT02070575

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy